Jiangxi Government To Set Prices For 797 Drugs Next Month
This article was originally published in PharmAsia News
Executive SummaryThe Jiangxi government will set prices for its newly amended list of government-priced drugs next month
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.